• scitechdaily.com

  08/06/2020

  

  COVID-19 Rates Significantly Higher Among Minority, Socioeconomically Disadva...

  Read more
• pharmacytimes.com

  08/06/2020

  

  Study: Antibiotics Linked to Higher Heart Disease Risk in Individuals with Ty...

  Read more
• newsroom.heart.org

  08/06/2020

  

  Heart Disease Medications Underused Among Hispanic/Latino Populations with PAD

  Read more

• • 

    

    Ewa A. Jankowska, MD, PhD, FESC

    Peer

  • 

    

    Stefan D. Anker, MD, PhD

    Peer

  3

  

  RestartResume

  RestartResume

  Beyond Anemia: Understanding the Significance and Treatment of Iron Deficiency

• • 

    

    Javed Butler, MD, MPH, MBA

    Peer

  2

  

  RestartResume

  RestartResume

  Mr. Jackson Moves to Town: Overcoming Challenges to Optimizing RAASi Therapy

• • 

    

    Sergio Fazio, MD, PhD

    Peer

  4

  

  RestartResume

  RestartResume

  Practical Considerations to Manage Residual ASCVD Risk

• • 

    

    Ileana L. Piña, MD, MPH, FAHA, FACC

    Peer

  • 

    

    Javed Butler, MD, MPH, MBA

    Peer

  • 

    

    Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA

    Peer

  12

  

  RestartResume

  RestartResume

  Examining Heart Failure Management: How Can We Do Better?

• • 

    

    Prof. Stephen Nicholls

    Peer

  • 

    

    Prof. Kausik Ray

    Peer

  1

  

  RestartResume

  RestartResume

  Examining LDL Cholesterol and Our Growing Therapy Options in Primary Prevention

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Brian P. McDonough, MD, FAAFP

    Peer

  17

  

  RestartResume

  RestartResume

  How Primary Care Clinicians on the Frontline Are Managing Patients During the...

• • 

    

    Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

    Peer

  • 

    

    C. Michael Gibson, MD, MS

    Peer

  26

  

  RestartResume

  RestartResume

  COVID-19 & Cardiovascular Considerations
• 1

  CME/CE Meeting

  

  Pri-Med East Annual Conference - Clin...

  Boston, Massachusetts

  December 02, 2020

  09:45 AM - 10:45 AM EST

  Learn more

Featured

• • 

    

    Jay L. Koyner, MD

    Peer

  • 

    

    Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP

    Peer

  • 

    

    John A. Kellum, MD, MCCM

    Peer

  9

  

  RestartResume

  RestartResume

  Early Recognition of Acute Kidney Injury: What’s the Role of Biomarkers?

• • 

    

    Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

    Peer

  • 

    

    Sergio Fazio, MD, PhD

    Peer

  • 

    

    Michael Miller, MD

    Peer

  16

  

  RestartResume

  RestartResume

  New Opportunities to Improve Management of Patients with or at High Risk of A...

• • 

    

    Alan S. Brown, MD, FNLA

    Peer

  16

  

  RestartResume

  RestartResume

  Triglyceride-Lowering Therapies: Addressing Gaps in the Guidelines

• • 

    

    Suneet Mittal, MD FACC FHRS

    Peer

  • 

    

    Aysha Arshad MD, FACC, FHRS, FAHA

    Peer

  21

  

  RestartResume

  RestartResume

  Telemedicine During COVID-19 Outbreak

• • 

    

    Andrew Epstein, MD

    Peer

  7

  

  RestartResume

  RestartResume

  5 Key Takeaways on Managing Afib in the Post-CABANA Era

• • 

    

    Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

    Peer

  • 

    

    Roger Blumenthal, MD

    Peer

  • 

    

    Robert H. Eckel, MD

    Peer

  • 

    

    Peter Libby, MD

    Peer

  • 

    

    R. Preston Mason, PhD

    Peer

  • 

    

    P. Gabriel Steg, MD

    Peer

  4

  

  RestartResume

  RestartResume

  REDUCE-IT Trial Studying Icosapent Ethyl: An In-Depth Review of USA Dataset w...

• • 

    

    C. Michael Gibson, MD, MS

    Peer

  • 

    

    Rod S. Passman, MD

    Peer

  • 

    

    Steven Steinbuhl, MD

    Peer

  22

  

  RestartResume

  RestartResume

  Consumer Wearable Technology for AF Screening, Detection, and Management: Bol...